Загрузка...
A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer
Cancer immunotherapies have generated remarkable clinical responses for some patients with advanced/metastatic disease, prompting exploration of rational combination therapies to bolster anti-tumor immunity in patients with limited response or those who experience tumor progression following an init...
Сохранить в:
| Опубликовано в: : | Cancer Immunol Immunother |
|---|---|
| Главные авторы: | , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Berlin Heidelberg
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8057655/ https://ncbi.nlm.nih.gov/pubmed/33880648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-021-02936-1 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|